Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-04 · accession 0001104659-22-055995 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-04 | 2022-05-04 | PTGX | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $4.21 | +15.7K | 584.0K | +3% | +$66.3K |
| D | 2022-05-04 | 2022-05-04 | PTGX | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $0.00 | -15.7K | 80.0K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-04 | M | A | 15,742 | $4.21 | 584,048 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-05-04 | M | D | 15,742 | $0.00 | 80,000 | D | $4.21 · — to 2026-04-29 | 15,742 Common Stock | (F1) The stock option is vested in full. |